We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.13 | -1.05% | 106.14 | 106.92 | 106.02 | 106.92 | 1,593,200 | 17:57:12 |
From Apr 2022 to Apr 2024
By Will Feuer
The U.S. Food and Drug Administration said it has secured an additional roughly 1.4 million pounds of baby formula that is expected to be available early next month.
Government officials and formula manufacturers are working to address a nationwide shortage that in recent months has resulted in empty shelves at some stores. Causes for the shortage include pandemic-related supply-chain snarls, a February recall by Abbott Laboratories, as well as the closing of one of its factories.
The agency said it has secured two products, Bellamy's Organic Infant Formula Step 1, which is for new-born children up to six months old, and Bellamy's Organic Follow-On Formula Step 2, which is for those between six months and 12 months old.
The agency said that the U.S. Department of Health and Human Services is evaluating options for getting the product to the U.S. as quickly as possible.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
June 27, 2022 09:52 ET (13:52 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
